AMPLY Discovery
Techstars '23Belfast, GB · 1 known investors
AMPLY Discovery is a UK-based biotech company that uses AI and computational biology to identify therapeutic targets in non-coding regions of the genome and develop first-in-class drugs through an integrated discovery platform combining machine learning with wet-lab validation. The company is developing therapeutics for oncology and drug-resistant infectious diseases, particularly antimicrobial-peptide and long non-coding RNA oligonucleotide programmes.
Founders & leadership
OR
Oliver RauschinCSO
Investors · 1
In the news
- AMPLY Discovery Receives Investment from Keeps Biomedfinsmes.com · 2026
- AMPLY Discovery Closes $1.75M Seed Fundingfinsmes.com · 2025
- Queen's University spin-out AMPLY Discovery secures $1.75M for AI drug discovery - Tech.eutech.eu · 2025
- Belfast-based AMPLY Discovery raises €1.6 million to tackle complex diseases with drug discovery platform | EU-Startupseu-startups.com · 2024
- Belfast-based AMPLY raises £900k to tackle drug-resistant pathogens with AI - AMPLY Discoveryamplydiscovery.com · 2022
- AMPLY Discovery - 2025 Company Profile, Funding, Competitors & Financials - Tracxntracxn.com · 2022